• Small Molecules
      • Discovery
    • Large Molecules
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

In the Media

Syngene COO On Delivering Cost Gains For mRNA Products
15th Aug, 2022
How CDMOs are Adapting to New mRNA Tech Demands
30th Jul, 2022
Why Indian Pharma Must Evolve As Value Creator
1st Jul, 2022
A Shifting Landscape - The outsourcing model is here to stay
10th Jun, 2022
Orphan drug development remains a specialised segment with limited players
10th Jun, 2022
Syngene interview in 2022 edition of USA Life Sciences report
10th Jun, 2022
CRAMS underpinned by strong technical expertise
9th Jun, 2022
Seeing Good Demand for Chemistry, Biology
6th May, 2022
Syngene to approach regulators for Mangalore unit audit in 12-18 months
5th May, 2022
Driven by big pharma needs, Syngene to focus on expanding breadth of services & capabilities
5th May, 2022

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To download, Please share your details

To download, Please share your details